INAF

Detail Analisis & Profil Saham

Skor Sentimen Berita

Netral

Rp 126

▲ Rp 0+0.00%

Deep AI Analysis

Analisis AI Belum Tersedia

Klik tombol "Perbarui Analisis" di atas untuk men-generate analisis teknikal dan fundamental secara instan.

Tentang Perusahaan

PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company operates through medicine, Medical devices and Others, and Engineering Pharmaceuticals. It engages in marketing, trading and distribution of medicine and medical devices; and clinical lab. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is based in Bekasi, Indonesia. The company operates as a subsidiary of PT Bio Farma.

Sektor

Healthcare

Industri

Drug Manufacturers - Specialty & Generic

Karyawan

Website

https://indofarma.id

Jajaran Direksi

Mr. Sahat Sihombing

President Director

Dr. Andi Prazos Apt, M.M.

Director of Operations & Director

Mr. Warjoko Sumedi

Head of Internal Audit Unit

Ms. Hilda Yani

Company Secretary

Ms. Weny Maulatsih

Secretary of Board of Commissioners

Struktur Kepemilikan

88.01%

Dimiliki Insiders

0.00%

Dimiliki Institusi

Jumlah Institusi

Valuasi Utama

PER

N/A

PBV

-0.55

MarketCap

0.39 T

DividendYield

N/A

Valuation_Status

Fair Value

Data Keuangan & Metrik

Total Pendapatan

168.11 M

EBITDA

-168.32 M

Total Utang

703.79 M

Kas Total

11.13 M

Gross Margin

-5.33%

Profit Margin

-35.96%

ROE

ROA

-21.30%

Indikator Momentum

RSI (14)

100

Overbought (Jenuh Beli)

MACD Status

Bearish Momentum

Support (30D)

126

Resistance (30D)

126

Volume & Tren MA

Volume Status (14D)

Normal

Moving Average (20)

126

Moving Average (50)

126

Weak Downtrend

Berita Terkini

WIKA, WSKT hingga INAF Masuk Daftar Hitam BEI, Terancam Delisting

Netral (50)

Suara.com•8/7/2026

Menanti nasib WIKA, WSKT, INAF: 3 emiten BUMN terancam delisting dari lantai BEI

Netral (50)

Katadata on MSN•7/7/2026

Terkini Bisnis: Kisah Pemegang Saham Indofarma yang Ditolak Ikut Rapat, Penjelasan RSCM tentang Banyak Anak Cuci Darah

Netral (50)

Tempo•26/7/2024

Kisah Seorang Pemuda Sukses Membalikkan Kerugian Ratusan Juta Rupiah dengan Meraup Puluhan Miliar di Saham Selama Pandemi

Negatif (25)

Liputan6•13/5/2023

Tidak ada berita Nasional terbaru.

Tidak ada berita Global terbaru.

Deep AI Analysis

Analisis AI Belum Tersedia

Tentang Perusahaan

Jajaran Direksi

Struktur Kepemilikan

Valuasi Utama

Data Keuangan & Metrik

Indikator Momentum

Volume & Tren MA

Berita Terkini

WIKA, WSKT hingga INAF Masuk Daftar Hitam BEI, Terancam Delisting

Menanti nasib WIKA, WSKT, INAF: 3 emiten BUMN terancam delisting dari lantai BEI

Terkini Bisnis: Kisah Pemegang Saham Indofarma yang Ditolak Ikut Rapat, Penjelasan RSCM tentang Banyak Anak Cuci Darah

Kisah Seorang Pemuda Sukses Membalikkan Kerugian Ratusan Juta Rupiah dengan Meraup Puluhan Miliar di Saham Selama Pandemi

Demam “Erickmologi BUMN”

Euforia Uji Klinis Bio Farma, Saham INAF dan KAEF Kena Auto Rejection

Perhatikan Saham SMRA, INAF, MYRX, MCOR